Roots Analysis

FEBRUARY 14, 2023

Presently, outsourcing of liposomes development and manufacturing related services has become a popular practice. Drug developers are actively outsourcing their operations to specialized repurposed-based service providers, which are known to have the required capabilities and expertise.

Development 52

Development Manufacturing Drug Delivery Systems Contract Manufacturing 52

Pharmaceutical Technology

FEBRUARY 27, 2023

Hydrocortisone is under clinical development by Antares Pharma and currently in Phase I for Adrenal Insufficiency. According to GlobalData, Phase I drugs for Adrenal Insufficiency have a 67% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. It is administered by parenteral route.

Drug Delivery 100

Drug Delivery Drug Delivery Systems Production Drugs 100

VirTrial

OCTOBER 9, 2020

The partnership will enable BetterLife to conduct remote patient monitoring for their imminent COVID 19 clinical trials in Australia to test the efficacy of AP-003, a proprietary interferon alpha 2b formulation. . The post VirTrial Selected for COVID-19 Phase 2 Decentralized Clinical Trial appeared first on VirTrial.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

Pharmaceutical Technology

JUNE 23, 2022

During the peak of the Covid-19 pandemic this challenge reached new heights, as pharmaceutical firms around the world mobilised the full might of their resources to try and identify, develop, and trial a wide range of vaccines and therapeutics to alleviate the lethal threat posed by the virus.

Trials 130

Trials Clinical Trials Clinical Trials Drug Delivery 130

Pharmaceutical Technology

NOVEMBER 21, 2022

RVAC Medicines has signed a master research partnership agreement with the Agency for Science, Technology and Research (A*STAR) for analysing and developing solutions to build messenger ribonucleic acid (mRNA) manufacturing and analytics expertise in Singapore.

Manufacturing 130

Manufacturing Medicine Vaccination Vaccine 130

Drug Discovery World

FEBRUARY 5, 2024

EXO Biologics has launched ExoXpert, a contract development and manufacturing organisation (CDMO) specialising in exosomes which offers a mesenchymal stem cells (MSC)-based exosome manufacturing platform used in European clinical trials.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing Gene Therapy 52

Drug Discovery World

AUGUST 4, 2022

However, starting early can greatly improve the efficiency and speed of the development process. This is especially true now, with the rise of drug-device combination products that demand sophisticated delivery systems. The increasing complexity of drug products has raised concern among pharmaceutical developers.

Containment 52

Containment Development Drugs Production 52

pharmaphorum

JULY 15, 2022

SAE Media Group’s 5th Annual Ophthalmic Drugs Conference will explore advancements in ophthalmic treatments and variety of novel drugs, which are showing good clinical trial data. Drug delivery will also be an important aspect of the agenda, with advancements in novel technologies. And many more!

Gene Therapy 52

Gene Therapy Drugs Drug Delivery Clinical Trials 52

XTalks

JUNE 14, 2023

The clinical trials consistently showed significant therapeutic improvements in ocular surface damage and associated symptoms, while pioneering visual function improvement analysis”, said John D. “The Attendees will understand best practices for novel drug delivery design and development. What Is Dry Eye Disease?

Gene Silencing 97

Gene Silencing Drug Delivery FDA Approval RNA 97

Pharmaceutical Technology

APRIL 4, 2023

The company will undertake a technology transfer and feasibility study for a drug product focused on the treatment of IPF at its centre of cell and gene expertise in Milan, Italy. Pre-clinical trials may begin later in 2023, if the feasibility study is successful. These vesicles are extracted from a bronchial epithelial cell.

Gene Therapy 130

Gene Therapy Gene Drug Delivery Medicine 130

pharmaphorum

OCTOBER 18, 2022

“Connected drug delivery devices play an important role in helping biopharmaceutical manufacturers understand and track key trends in patient adherence,” said Matthew Schabacker, general manager of BD’s advanced drug delivery unit.

Drug Delivery 52

Drug Delivery Manufacturing Drugs Marketing 52

Drug Discovery World

OCTOBER 18, 2023

Sara Donnelly, Director of Research Planning and Business Development at PhoenixBio USA explores why the right pre-clinical model is essential for teams wanting to advance adeno-associated virus vector-based gene therapies.

Gene Therapy 64

Gene Therapy Gene Clinical Trials Clinical Trials 64

Roots Analysis

MARCH 2, 2022

Interestingly, recent advances in this domain have led to the development of several treatment strategies that, according to developers, exhibit the necessary capabilities to overcome challenges posed by traditional oral protein formulations and peptide-based therapies. Oral Protein / Peptide-based Drugs. Web: [link].

Protein 52

Protein Drug Delivery Drugs Drug Delivery Systems 52

Drug Discovery World

AUGUST 19, 2022

Respira is currently developing inhaled therapeutics for smoking cessation and drug delivery technologies to treat cardiopulmonary diseases. The company is in the midst of securing financing for clinical trials. Respira’s founder, Mario Danek, will transition to the role of Chief Technology Officer (CTO).

Drug Delivery 52

Drug Delivery Clinical Trials Clinical Trials Production 52

pharmaphorum

NOVEMBER 7, 2022

The conference will explore advancements in ophthalmic treatments and variety of novel drugs, which are showing great clinical trial data. There will also be a specific focus on drug delivery along with advancements in novel technologies. The conference is co-chaired by Mitchell A.

Drugs 52

Drugs Clinical Trials Clinical Trials Gene Therapy 52

Roots Analysis

MARCH 16, 2022

In order to promote the use of exosomes in various therapeutic applications including targeted drug delivery vehicles, engineered exosomes and many more, there are a number of companies that offer services related to the isolation, purification, characterization or quantification of exosomes. Broad Clinical Trial Landscape.

Marketing 59

Marketing Manufacturing Drug Delivery Drug Delivery Systems 59

pharmaphorum

MAY 26, 2021

per share takeover by US private investment company Carlyle, which values the UK drug delivery specialist at £958 million ($1.4 Vectura has agreed to a £1.55 billion). . ” Investors seemed to share that view, as shares in Vectura leaped by almost a third after the announcement.

Drug Delivery 64

Drug Delivery Sales Drugs Clinical Trials 64

The Pharma Data

JANUARY 31, 2021

(CSI ® ) (NASDAQ: CSII) announced today that it has partnered with Chansu Vascular Technologies, LLC (CVT) to develop novel peripheral and coronary everolimus drug-coated balloons (DCBs). This collaboration enables us to develop a new class of DCBs that we believe will improve patient outcomes.”. Cardiovascular Systems, Inc.,

Development 52

Development Drugs Production Containment 52

The Pharma Data

SEPTEMBER 11, 2020

This week’s round up dives into developments from companies based in Australia and the US. Starpharma experimenting with Gilead’s antiviral drug for easier administration. Melbourne-based Starpharma has announced it has applied its novel DEP drug delivery technology to create a long ? Saama Technologies, Inc. ,

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

pharmaphorum

NOVEMBER 25, 2022

There are clearly challenges to developing a drug targeting a rare disease, due to the small and often undiagnosed populations, and these challenges are also present when developing an accurate forecast of their market potential. Data and market insights. Case study: severe asthma. Scenario planning and forecasting.

Marketing 122

Marketing Clinical Trials Clinical Trials Production 122

pharmaphorum

MARCH 15, 2022

Sanofi has agreed a deal with life sciences investor Blackstone to help fund clinical trials of a new formulation of Sarclisa for blood cancer multiple myeloma, accelerating its development. Sanofi has partnered with drug delivery specialist Enable Injections to develop the subcutaneous formulation.

Trials 93

Trials Sales Drug Delivery Antibody 93

Roots Analysis

SEPTEMBER 1, 2023

The integration of the blue ocean strategy in healthcare landscape, often known as blue ocean therapy, and its application in medical product development, such as blue ocean medical products, is the silver lining that can revolutionize the industry. This strategy is not a silver bullet; it’s a calculated voyage into uncharted waters.

Drug Delivery 52

Drug Delivery Marketing Drug Delivery Systems Drugs 52

Drug Discovery World

JANUARY 19, 2023

They are called “ Innovation, investment and commitment: Genentech’s approach to the future of ophthalmology ” and “ Innovative delivery of sustained ophthalmic steroids for high unmet needs in diabetic macular edema ”. You can also find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts.

Drug Delivery 52

Drug Delivery Drugs Medicine Development 52

Drug Discovery World

JUNE 7, 2023

pHion is developing a pipeline of therapeutic and prophylactic vaccines focussed on oncology and infectious diseases. Infection with HPV is responsible for approximately 90% of cervical cancers and up to 70% of oropharyngeal cancers, with a high unmet clinical need.

Vaccination 52

Vaccination Vaccine Drug Delivery Systems Drug Delivery 52

BioSpace

NOVEMBER 17, 2022

Editas Medicine is pausing its ocular gene therapy program after demonstrating a favorable safety profile and seeking a potential partner to develop EDIT-101, the company announced Thursday.

Gene Therapy 42

Gene Therapy Gene Gene Editing Medicine 42

Pharmaceutical Technology

NOVEMBER 7, 2022

SHL Medical is a world-leading solutions provider for advanced drug delivery systems with a unified purpose to further enable patient independence. The Charleston Regional Development Alliance (CRDA) is supporting SHL Medical by facilitating valuable connections to best-in-class service providers in the area.

Production 130

Production Life Science Manufacturing Drug Delivery Systems 130

XTalks

JUNE 15, 2022

Royal Philips has been researching and developing treatment for critical limb ischemia. In 2018, the commpany announced the Stellarex 0.014″ Drug-Coated Balloon for below-the-knee PTA. These results were collected from a three-year follow-up in the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee clinical trial.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

pharmaphorum

JANUARY 12, 2023

The life sciences unit of Google parent Alphabet – which raised $1 billion back in September to fund its precision health agenda and business development activities, including possible acquisitions – said the move would allow it to streamline its operations.

Drug Delivery 69

Drug Delivery Life Science Production Engineer 69

Roots Analysis

FEBRUARY 18, 2022

The key focus of these studies is on the development of anti-tumor therapeutics. CLINICAL TRIALS EVALUATING MYELOID CELLS TAREGTING THERAPEUTICS. In the past decade, more than 1,500 clinical trials have been registered for evaluating drug therapies targeting myeloid cells. Our Social Media Platform.

Drug Delivery Systems 52

Drug Delivery Systems Immune Response Clinical Trials Clinical Trials 52

The Pharma Data

JANUARY 3, 2021

04, 2021 (GLOBE NEWSWIRE) — TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, announced today that its subsidiary, InspirMed Inc., The inhalable liposome drug was also found to be less toxic than the free drug.

Clinical Trials 52

Clinical Trials Clinical Trials Containment Development 52

pharmaphorum

OCTOBER 6, 2022

Click chemistry refers to molecular building blocks snapping together quickly and efficiently, and its development responded to the need to for pharmaceutical researchers to build increasingly complicated molecules. Barry Sharpless “for the development of click chemistry and bioorthogonal chemistry.” Bertozzi, Morten Meldal and K.

Drug Delivery 52

Drug Delivery DNA Medicine Research 52

The Pharma Data

DECEMBER 20, 2020

With this acquisition we are expanding our product pipeline to include psychedelic therapeutics, incorporating elements of our IP around drug delivery technology in which we already have prototypes developed, which we believe will propel us towards clinical studies relatively quickly. Ahmad Doroudian, CEO of BetterLife.

Drug Delivery 52

Drug Delivery Containment Production Development 52

Roots Analysis

MARCH 3, 2022

Since the approval of Soliris® in 2007, an anti-C5 antibody, the field of complement drug discovery has gained significant attention. Currently, nine complement therapeutics are commercially available, while around 190 molecules are under development for various disease indications. Broad Clinical Trial Landscape.

Drug Delivery Systems 52

Drug Delivery Systems Marketing Immune Response Dermatology 52

Roots Analysis

OCTOBER 13, 2023

Over the last two decades the pharmaceutical industry has observed a paradigm shift from conventional drug delivery strategies to more enhanced, potent, and targeted therapeutics. This led the researchers to find alternative pathways and drug delivery strategies to enhance the potent delivery of the drug to the site of action.

Drugs 40

Drugs Antibody RNA Genetics 40

The Pharma Data

MARCH 15, 2022

Investment will accelerate the overall Sarclisa ® development program Sanofi will continue to fully manage the clinical program and retain full rights and control of Sarclisa ® (isatuximab). to advance the development of a subcutaneous delivery for Sarclisa ® with the goal of offering a unique patient-centric treatment experience.

Life Science 52

Life Science Antibody Clinical Trials Clinical Trials 52

Drug Discovery World

SEPTEMBER 13, 2023

Integrated drug formulation and clinical trials company, BDD Clinical Trials, has secured a further round of investment for £2M to aid the company’s expansion in response to growing demand for both its patented drug delivery technology and specialist clinical trial services.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

The Pharma Data

OCTOBER 20, 2020

21, 2020 (GLOBE NEWSWIRE) — TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage, specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced the appointment of Thomas H. Earlier in his career, he ran business-development functions at Amgen and Baxter.

Licensing 40

Licensing Licensing Drug Delivery Business Development 40